1. P. Viswanathan, Y. Muralidaran, G. Ragavan, Challenges in oral drug delivery: A nano-based strategy to overcome, in: Nanostructures Oral Med., (2017) pp. 173–201. https://doi.org/10.1016/B978-0-323-47720-8.00008-0.
2. Design and development of mucoadhesive acyclovir tablet;Dias;Iran. J. Pharm. Res.,2009
3. CDER, New Drugs at FDA: CDER’s New Molecular Entities and New Therapeutic Biological Products, FDA. (2016). https://www.fda.gov/drugs/development-approval-process-drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products (accessed October 23, 2020).
4. A clinician’s guide to oral extended-release drug delivery systems in epilepsy;Wheless;J. Pediatr. Pharmacol. Ther.,2018
5. How to modify drug release in paediatric dosage forms? Novel technologies and modern approaches with regard to children’s population;Trofimiuk;Int. J. Mol. Sci.,2019